These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2501553)

  • 1. [Aggregative function of thrombocytes and the status of the anticoagulation system of the blood in patients with ischemic heart disease during treatment with nitroderm].
    Zadionchenko VS; Kamenker ES; Smirnov VK; Akhmedova FD; Vasil'ev KA
    Klin Med (Mosk); 1989 Mar; 67(3):72-3. PubMed ID: 2501553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].
    Avellone G; Mandalà V; Novo S; Davì G; Pinto A; Riolo FP
    Boll Soc Ital Cardiol; 1979; 24(11):1229-33. PubMed ID: 261907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on platelets and coagulofibrinolytic system in ischemic heart disease].
    Kuroiwa Y
    Igaku Kenkyu; 1988 Dec; 58(6):383-95. PubMed ID: 2978105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of nitroglycerin on indices of hemodynamics and primary hemostasis in ischemic heart disease patients during aortocoronary shunting].
    Seleznev MI; Mikhaĭlov IuE; Smirnova LA; Flerov EV; Egorova IA
    Vestn Akad Med Nauk SSSR; 1986; (6):28-33. PubMed ID: 3092492
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet function and antithrombin, plasminogen, and fibrinolytic activities in cats with heart disease.
    Welles EG; Boudreaux MK; Crager CS; Tyler JW
    Am J Vet Res; 1994 May; 55(5):619-27. PubMed ID: 8067608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of using nitroderm in ischemic heart disease].
    Mikunis RI; Bogach NT; Serkova VK; Semenenko IF; Monastyrskiĭ IuI
    Klin Med (Mosk); 1986 Jun; 64(6):33-7. PubMed ID: 3091905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of 2 drug forms of nitroglycerin--transdermal (preparation Nitroderm-TTS) and gingival application (preparation Trinitrolong)--in ischemic heart disease patients].
    Metelitsa VI; Martsevich SIu; Piotrovskiĭ VK; Riabokon' OS; Blagodatskikh SV
    Ter Arkh; 1986; 58(6):58-62. PubMed ID: 3094187
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiplatelet therapy and platelet function studies in elderly patients with ischemic heart disease--evaluation of whole blood platelet aggregation].
    Kawamura H; Kodama H; Takeuchi G; Kohsaka K; Suzuki S; Nitta M; Takada K; Mitomo Y; Yamamoto M
    Rinsho Ketsueki; 1986 Oct; 27(10):1815-22. PubMed ID: 3820607
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional status of thrombocytes in patients with acute forms of ischemic heart disease].
    Kakuliia MSh; Panchenko VM
    Klin Med (Mosk); 1987 Jan; 65(1):88-92. PubMed ID: 3560837
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of essential phospholipids on the lipid spectrum of blood plasma and the aggregative capacity of thrombocytes in patients with ischemic heart disease].
    Botolova EN; Solov'ev VV; Ozerova IN; Polesskiĭ VA; Pomykalov SV
    Kardiologiia; 1988 Sep; 28(9):57-61. PubMed ID: 3236647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood platelet function in patients with coronary disease after administration of acetylsalicylic acid and dipyridamole].
    Olszańska-Skorek T; Mazurowa A; Pełczyńska I; Chojnowski K; Hołub A; Drzewoski J
    Pol Tyg Lek; 1983 Feb; 38(9):269-72. PubMed ID: 6866846
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombocytic hemostasis in the complex treatment of patients with ischemic heart disease].
    Khimenko PL; Nikitin AE
    Vrach Delo; 1985 May; (5):53-6. PubMed ID: 2861693
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet aggregates in ischemic heart disease.
    Schwartz MB; Hawiger J; Timmons S; Friesinger GC
    Thromb Haemost; 1980 Jul; 43(3):185-8. PubMed ID: 7455982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Observation of plasma levels of antithrombin-III and plasminogen in acute cerebrovascular disease].
    Lu J
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):205-7, 252-3. PubMed ID: 2620588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rehabilitation in myocardial infarct. Study of various coagulation parameters and platelet function].
    Gibelli A; Fiorini GF; Renoldi P; Schweiger C; Piazza A; Paracchini ML
    Minerva Med; 1983 May; 74(21):1279-84. PubMed ID: 6190108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties of thrombocytes in patients with ischemic heart disease].
    Sopina NV
    Vrach Delo; 1987 Apr; (4):39-41. PubMed ID: 3617634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiaggregants of thrombocytes in ischemic heart disease].
    Beloev I ; Tomov I; TŭrnovskaR
    Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacologic aspects of thrombophilia].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):535-49. PubMed ID: 6083924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III in ischemic cardiopathy].
    Avellone G; Davì G; Pinto A; Mandalà V
    Boll Soc Ital Cardiol; 1979; 24(2):127-33. PubMed ID: 548088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of the antithrombin III level and plasminogen activator activity in patients with thrombophlebitis].
    Tymiński W; Czestochowska E; Swiecicki P
    Pol Tyg Lek; 1985 Oct; 40(43):1202-4. PubMed ID: 4088936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.